Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study
- 1 May 2011
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 377 (9779) , 1770-1776
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trialThe Lancet Infectious Diseases, 2011
- Advances and challenges in malaria vaccine developmentJournal of Clinical Investigation, 2010
- Cardiac complication after experimental human malaria infection: a case reportMalaria Journal, 2009
- Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trialsThe Lancet, 2009
- Long‐Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican ChildrenThe Journal of Infectious Diseases, 2009
- Protection against a Malaria Challenge by Sporozoite InoculationNew England Journal of Medicine, 2009
- Acquired Immunity to MalariaClinical Microbiology Reviews, 2009
- Placental Plasmodium falciparum infection: Causes and consequences of in utero sensitization to parasite antigensMolecular and Biochemical Parasitology, 2007
- A Systematic Map of Genetic Variation in Plasmodium falciparumPLOS Pathogens, 2006
- Is Immunity to malaria really short-lived?Parasitology Today, 1992